Top 7 From F1000

Top 7 From F1000 James Cavallini / Photo Researchers, Inc. 1. Immune response feeds parasite » Salmonella is able to outcompete resident gut microbes by deriving energy from the inflammatory immune response that is supposed to combat the pathogen.S.E. Winter et al., Nature, 467:426-29, 2010. Evaluated by P. Malik-Kale & O. Steele-Mortimer, NIAID; E. Guccione & D. Kelly, Univ Sheffield; M. Vijay-Kumar & A. Gewirtz, Emory Univ; D. Alpers, Wa

Written byThe Scientist
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

1. Immune response feeds parasite » Salmonella is able to outcompete resident gut microbes by deriving energy from the inflammatory immune response that is supposed to combat the pathogen.

S.E. Winter et al., Nature, 467:426-29, 2010. Evaluated by P. Malik-Kale & O. Steele-Mortimer, NIAID; E. Guccione & D. Kelly, Univ Sheffield; M. Vijay-Kumar & A. Gewirtz, Emory Univ; D. Alpers, Wash Univ School of Med; A. Kurakin & R. Khosravi-Far, Beth Israel Deaconess Med Cen; M. Hensel, Univ Osnabrück; Y. Sun & M. O’Riordan, Univ Mich Med School; W.D. Hardt, Swiss Fed Inst of Tech; J. Moir, Univ York; V. Nizet, UCSD. Free F1000 Evaluation

2. Lung disease drug kind to muscles » Patients with acute respiratory distress syndrome using a neuromuscular blocker are more likely than those on a placebo to survive 90 days, and show no increase in muscle weakness—a common concern among doctors.

L. Papazian et al., ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies